Loading…
* Free cash flow = OCF − net investing outflow (the filings carry no standalone capex line).
Operates in Pharma — Distribution. Per the activity note to the FY2024 annual report, the company engages in wholesale trade of pharmaceutical products. Based in Tbilisi's Isani district; founded by Gogita Mebonia and Irakli Mebonia.
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 2,207 | 2,597 | 2,815 | 3,286 | 3,601 | 3,336 | 3,548 | 3,422 | +6.5% |
| Total COGS | 1,674 | 2,084 | 2,217 | 2,414 | 2,766 | 2,468 | 2,453 | 2,315 | +4.7% |
| Gross Profit | 534 | 513 | 597 | 873 | 835 | 868 | 1,095 | 1,107 | +11.0% |
| Gross Margin | 24.2% | 19.7% | 21.2% | 26.6% | 23.2% | 26.0% | 30.9% | 32.3% | |
| 104 | 123 | 94 | 110 | 115 | 149 | 228 | 272 | +14.7% | |
| EBITDA | 429 | 390 | 503 | 762 | 721 | 719 | 867 | 835 | +10.0% |
| EBITDA Margin | 19.4% | 15.0% | 17.9% | 23.2% | 20.0% | 21.5% | 24.4% | 24.4% | |
| Total D&A | 11 | 7 | 10 | 13 | 10 | 8 | 7 | 3 | -15.1% |
| EBIT / Operating Income | 419 | 383 | 493 | 750 | 711 | 710 | 860 | 831 | +10.3% |
| 79 | 3 | 44 | 28 | 23 | 43 | 11 | 64 | nmf | |
| Profit Before Tax | 498 | 380 | 449 | 722 | 733 | 753 | 872 | 767 | +6.4% |
| Total Income Tax | 0 | 4 | 2 | 67 | 44 | 74 | 151 | 140 | +80.9% |
| Net Profit / (Loss) | 376 | 339 | 447 | 606 | 636 | 679 | 721 | 627 | +7.6% |
| Net Margin | 17.0% | 13.0% | 15.9% | 18.4% | 17.7% | 20.4% | 20.3% | 18.3% |
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Ownership & directors from companyinfo.ge (public corporate registry).
Ranked by how close each latest revenue is to this one — not a curated comp set.